Kepos Capital LP Emergent Bio Solutions Inc. Transaction History

Kepos Capital LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 13, 2019	SELL	$40.6 - $57.2 $786,137 - $1.11 Million	-19,363 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$39.92 - $53.86 $1.15 Million - $1.55 Million	-28,856 Reduced 59.84%	19,363 $935,000
Q2 2018 Aug 13, 2018	BUY	$48.33 - $55.64 $1.84 Million - $2.12 Million	38,085 Added 375.81%	48,219 $2.44 Million
Q1 2018 May 14, 2018	BUY	$44.44 - $54.39 $450,354 - $551,188	10,134 New	10,134 $534,000

160

33.8M

453K

931K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $438M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of Kepos Capital LP, based on Form 13F filings with the SEC.

Stay updated on Kepos Capital LP with notifications on news.